1. Muenster T, Mueller C, Forst J, Huber H, Schmitt HJ. Anaesthetic management in patients with Duchenne muscular dystrophy undergoing orthopaedic surgery: a review of 232 cases. Eur J Anaesthesiol. 2012; 29:489–94. DOI:
10.1097/EJA.0b013e3283566789. PMID:
22801582.
2. Ririe DG, Shapiro F, Sethna NF. The response of patients with Duchenne's muscular dystrophy to neuromuscular blockade with vecuronium. Anesthesiology. 1998; 88:351–4. DOI:
10.1097/00000542-199802000-00013. PMID:
9477055.
3. Wick S, Muenster T, Schmidt J, Forst J, Schmitt HJ. Onset and duration of rocuronium-induced neuromuscular blockade in patients with Duchenne muscular dystrophy. Anesthesiology. 2005; 102:915–9. DOI:
10.1097/00000542-200505000-00009. PMID:
15851877.
4. Ramachandran SK, Mathis MR, Tremper KK, Shanks AM, Kheterpal S. Predictors and clinical outcomes from failed Laryngeal Mask Airway Unique™: a study of 15,795 patients. Anesthesiology. 2012; 116:1217–26. DOI:
10.1097/ALN.0b013e318255e6ab. PMID:
22510864.
5. Boland BJ, Silbert PL, Groover RV, Wollan PC, Silverstein MD. Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy. Pediatr Neurol. 1996; 14:7–12. DOI:
10.1016/0887-8994(95)00251-0.
6. Segura LG, Lorenz JD, Weingarten TN, Scavonetto F, Bojanić K, Selcen D, et al. Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures. Paediatr Anaesth. 2013; 23:855–64. DOI:
10.1111/pan.12248. PMID:
23919455.
7. Shin HH, Park DH, Lee C, Woo SC, Kim YJ, Joo JH, et al. Anesthesia for a 10-year-old boy with Duchenne muscular dystrophy syndrome: a case report. Korean J Anesthesiol. 2008; 55:217–20. DOI:
10.4097/kjae.2008.55.2.217.
8. Frankowski GA, Johnson JO, Tobias JD. Rapacuronium administration to two children with Duchenne's muscular dystrophy. Anesth Analg. 2000; 91:27–8. DOI:
10.1213/00000539-200007000-00005. PMID:
10866881.
9. Buzello W, Krieg N, Schlickewei A. Hazards of neostigmine in patients with neuromuscular disorders. Report of two cases. Br J Anaesth. 1982; 54:529–34. DOI:
10.1093/bja/54.5.529. PMID:
7073921.
10. Schmidt J, Muenster T, Wick S, Forst J, Schmitt HJ. Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy. Br J Anaesth. 2005; 95:769–72. DOI:
10.1093/bja/aei249. PMID:
16183677.
11. Capozzoli G, Auricchio F, Accinelli G. Total intravenous anaesthesia without muscle relaxants in a child with diagnosed Duchenne muscular dystrophy. Minerva Anestesiol. 2000; 66:839–40. PMID:
11213553.
12. Cossu F, Caboni MT. Propofol in Duchenne muscular dystrophy. Minerva Anestesiol. 1995; 61:51–3. PMID:
7617241.
13. Kim JE, Chun HR. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: a case Report. Medicine (Baltimore). 2017; 96:e6456. DOI:
10.1097/MD.0000000000006456. PMID:
28353578. PMCID:
PMC5380262.
14. Wefki Abdelgawwad Shousha AA, Sanfilippo M, Sabba A, Pinchera P. Sugammadex and reversal of neuromuscular block in adult patient with duchenne muscular dystrophy. Case Rep Anesthesiol. 2014; 2014:680568. DOI:
10.1155/2014/680568.